Early research (Phase 1)Study completedNCT00720148What this trial is testingA Phase I Trial of Bortezomib and SunitinibWho this might be right forSolid Tumors Emory University 30
Testing effectiveness (Phase 2)Study completedNCT00556049What this trial is testingCombination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell CarcinomaNeoplasm Metastases Massachusetts General Hospital 72
Testing effectiveness (Phase 2)Study completedNCT02623127What this trial is testingSunitinib in Patients With Metastatic or Recurrent Thymic CarcinomaWho this might be right forThymic Carcinoma Seoul National University Hospital 25
Not applicableLooking for participantsNCT07024680What this trial is testingReal World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCCWho this might be right forPapillary Renal Cell Carcinoma AstraZeneca 150
Not applicableEnded earlyNCT01740154What this trial is testingSunitinib Malate Related Fatigue in Patients With Metastatic Kidney CancerWho this might be right forFatigueRecurrent Renal Cell CancerStage IV Renal Cell Cancer Case Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT02761057What this trial is testingTesting Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has ProgressedWho this might be right forLocally Advanced Papillary Renal Cell CarcinomaMetastatic Papillary Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+4 more National Cancer Institute (NCI) 152
Not applicableStudy completedNCT00849186What this trial is testingSunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney CancerWho this might be right forKidney Cancer Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT04193553What this trial is testingMulticentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib FailureWho this might be right forGastro Intestinal Stromal Tumour Centre Leon Berard 77
Testing effectiveness (Phase 2)Study completedNCT00372775What this trial is testingStudy Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain MetastasesWho this might be right forNon-Small Cell Lung Cancer Pfizer 66
Testing effectiveness (Phase 2)Study completedNCT02230176What this trial is testingAntitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase IIWho this might be right forPancreatic Neuroendocrine Carcinoma Gustave Roussy, Cancer Campus, Grand Paris 84
Testing effectiveness (Phase 2)Study completedNCT00695292What this trial is testingIrinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung CancerWho this might be right forSmall Cell Lung Cancer SCRI Development Innovations, LLC 37
Large-scale testing (Phase 3)UnknownNCT00869011What this trial is testingExercise for Patients With Renal Cell Cancer Receiving SunitinibWho this might be right forRenal Cell Carcinoma Charite University, Berlin, Germany 70
Not applicableStudy completedNCT01058044What this trial is testingAdherence to Oral Anticancer Treatment Using Electronic Monitoring SystemWho this might be right forCancer Centre Jean Perrin 33
Testing effectiveness (Phase 2)Ended earlyNCT00609622What this trial is testingRandomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal CancerWho this might be right forColorectal Neoplasms Pfizer 191
Testing effectiveness (Phase 2)Study completedNCT00514137What this trial is testingSunitinib in Treating Patients With Relapsed Multiple MyelomaWho this might be right forRefractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT00247676What this trial is testingAn International Phase 2 Study Of SU011248 In Patients With Inoperable Liver CancerWho this might be right forLiver NeoplasmsUnresectable Hepatocellular Carcinoma Pfizer 37
Testing effectiveness (Phase 2)Study completedNCT00137423What this trial is testingStudy Of SU011248 (Sunitinib) Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell CancerWho this might be right forCarcinoma, Renal Cell Metastasis Pfizer 107
Not applicableStudy completedNCT04415697What this trial is testingIdentification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal CarcinomasWho this might be right forKidney CancerBiomarkersGene Expression Barretos Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00299741What this trial is testingStudy of SU11248 in Men With Advanced Prostate CancerWho this might be right forProstate Cancer Massachusetts General Hospital 36
Early research (Phase 1)Study completedNCT00631410What this trial is testingStudy Of Sunitinib In Combination With Folfox In Patients With Colorectal CancerWho this might be right forColorectal Neoplasms Pfizer 12